Market Access Benchmark Advisory

Life sciences manufacturers continue to struggle with achieving the optimal and cost-effective market access strategy due to challenges in four key areas:

  • Benchmarking distribution models and pharmacy network composition.
  • Sizing and segmenting pharmacies and provider accounts based on demand for a competitive product group.
  • Insight to the prevalence and terms and conditions of Payer, GPO, Health System, Distributor and Pharmacy contracts.
  • Benchmarking Gross-to-Net line items against a market basket of analogous products.

Download now!

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article